S. Pfister

Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial.

C. Correll, J. Ouyang, R. Mcquade, 2015, The American journal of psychiatry.

A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia

J. Kane, J. Ouyang, R. Mcquade, 2015, Schizophrenia Research.

A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults with Schizophrenia

J. Ouyang, A. Forbes, M. Hobart, 2018, The international journal of neuropsychopharmacology.

Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study

E. Weiller, J. Ouyang, R. Mcquade, 2016, The international journal of neuropsychopharmacology.

Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study

E. Weiller, J. Ouyang, R. Mcquade, 2016, The international journal of neuropsychopharmacology.

Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial.

C. Correll, J. Ouyang, R. Mcquade, 2015, The American journal of psychiatry.